Navigation Links
Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
Date:9/10/2007

e, Web based application that places all of a member's high-level information in one secure location. The Toolbar was originally launched at WellPoint companies in California, Georgia, Missouri and Wisconsin. The success of the initial release of the MAS Toolbar has prompted WellPoint to replicate the online program in nine additional states.

Online Pre-Certifications

For some healthcare services, a pre-certification from the insurer to the provider is required. The MyInsuranceManager Web Precert Program (Web Precert) is BlueCross BlueShield of South Carolina's (BCBSSC) innovative program that streamlines the pre-certification process making it more efficient and less costly. By updating their pre-certification process from fax and telephone to an online process, providers are able to receive real-time resolution to some pre-certification requests. Currently, over 46 percent of all pre-certification requests and inquiries are handled online, greatly reducing the use of long-distance telephone calls. BCBSSC has achieved cost savings thanks to Web Precert. If current trends continue, cumulative costs savings due to Web Precert would total $1.4 million by the end of 2007.

Improving Claim Processing

At Blue Cross and Blue Shield of Illinois (BCBSIL), claims processing is a joint responsibility between the insurer and the Medical Groups/Independent Practice Associations (MG/IPA). By forming the Medical Group Advisory Committee, BCBSIL staff was able to improve administrative issues that either slowed or created mistakes in claims processing. Through this collaborative effort of adopting a more efficient process, past due claims sent to MG/IPAs for review dropped from more than 8,400 to only 816 in the same period the following year.

On September 14, 2007, BCBSA is holding a forum at the National Press Club in Washington, D.C., to promote how insurers and providers are working together to improve healthcare quality and patient safety. Rep
'/>"/>

SOURCE Blue Cross Blue Shield Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...gulatory Authority Over Tobacco, WASHINGTON, Ma...est,Hispanic faith-based organization in the count...he Family Smoking Prevention and Tobacco Control,A...y over tobacco products., "We encourage Congres...R. 1108 has broad bi-partisan support and could ge...
(Date:5/11/2008)...Biotechnology and Biological Sciences Research Cou...o investigate important aspects of human ageing. ...niversity, Dr Lynne Cox and Dr Robert Saunders hav...s can now be used to study the effects ageing has ...l Aging Cell, the researchers demonstrate the valu...
(Date:5/11/2008)...swire-USNewswire/ -- The situation for children,co...ren have been separated,from their families, many ...camps, and some are drinking water from ponds cove...., The information is contained in a new situatio...mar. It details the most urgent needs of women,and...
(Date:5/11/2008)... waiting, bracing and, sometimes, surgery, , ... spines are naturally curved and flexible so that ...some people, the natural curve of the spine doesn,...r "C" shape. , This condition is known as scoli...ording to the National Scoliosis Foundation. While...
Breaking Medicine News(10 mins):Health News:Human aging gene found in flies 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 2Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 3Health News:UNICEF REPORT: Desperate Conditions for Children in Camps Without Clean Water as Cyclone Aftermath Worsens 4Health News:Scoliosis: An Unnatural Curve 2Health News:Scoliosis: An Unnatural Curve 3
...g to new study some light was thrown on the vision...y the condition. The study focuses on the risk of ...least 2 percent of the population is born with amb...y countries routinely screen for lazy eye. The goa...
...g to new research finds heart patients who are giv...er risk of returning to the hospital for chest pai..., England //say that the reduced risk was not rel... playing a role in heart disease. The effect was s...
...ers in a new survey observe that many people are s...sk factors. Oral and throat cancers account for ab...n be investigated by a dentist and early diagnosis...ey by dental experts at New York University shows,...
...long period of study, it shows little difference i...east surgery. The radical mastectomy - total remov...- is far less often done nowadays as a treatment f... for a simple mastectomy or even a lumpectomy, whi...
Other Medicine News:
(Date:5/8/2008)...TON, May 8 /- The Cancer Research All...on,s top cancer centers, is asking,303 million Ame...ting $1 to,cancer research efforts this Mother,s D...e "Infinite Power of One(TM)" has two key goals:,t...to their own hands by,joining together to exercise...
(Date:5/8/2008)...PA, Fla., May 8 /- Alpharma...ical company, today announced results from,clinica... sulfate,extended-release with sequestered naltrex...y relevant features addressing abuse liability,alo...e Phase I and II,studies, presented at the 27th An...
(Date:5/8/2008)... HAVEN, Conn., May 8 /- VIO...ounced the start of an investigator-sponsored,Phas... Cloretazine(R),(VNP40101M) in combination with cy...ated acute myelogenous leukemia (AML) and high-ris...ing conducted under the,direction of Ellen K. Ritc...
(Date:5/8/2008)...orial Sloan-Kettering Cancer Center Investigators ...ve Ovarian Cancer Patients -, BRISBANE, Calif., M...nounced the expansion of Phase 2 clinical trial pr...ancer. This is the third major clinical trial,of B...s, expanding on,on-going trials in breast and brai...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Link between chronic kidney disease and oxygen deprived tissue 8460 1Link between chronic kidney disease and oxygen deprived tissue 8460 2Dolphin therapy a dangerous fad Emory researchers warn 1644 1Dolphin therapy a dangerous fad Emory researchers warn 1644 2Dolphin therapy a dangerous fad Emory researchers warn 1644 3A research of the UGR shows the genetic predisposition to develop alcohol abuse 1640 1A research of the UGR shows the genetic predisposition to develop alcohol abuse 1640 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4
...ent Preclinical Data From Study of,Oral Formulatio...SBURG, Md., April 10, 2007 (PRIME,NEWSWIRE) -- Inf...mmune, Inc. (Nasdaq:MEDI) today announced that dat...n of IPI-504 in non-small,cell lung cancer (NSCLC)...of the American Association for Cancer Research (A...
...rated and Potentially Suited for Once,Daily Admini...ire-FirstCall/ --,Pharmacopeia , an innovator in t...le therapeutics, today announced positive results,...0, the company,s,lead internal product candidate f...ropathy. Data from the single ascending dose (SAD)...
Other Medicine Technology:Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 2Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 5
Calcitonin EIA Bone and Mineral Metabolism 021-SDX017
...-GBM was developed to detect the presence of antib...e information is clinically useful in diagnosing G...3 chain antibody formation along with glomerulonep...stic parameters. Since there are several other con...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase
Circulating Immune Complexes from patient serum or plasma, standards and controls are incubated with human C1q absorbed onto microtiter wells. After a washing step, an alkaline phosphatase labeled c
Medicine Products: